Back to Treatments

Treatment

Gemtuzumab Ozogamicin (GO) + Chemotherapy

1
Conditions
21
Trials
5,000
Participants
30%
Average Safety

Condition Evidence

Acute myeloid leukemia

21 trials · 5,000 participants

76% effectiveness · 30% safety
Gemtuzumab Ozogamicin (GO) + Chemotherapy | DFDA